Monitoring Hodgkin’s lymphoma patients with positron-emission tomography (PET) scans during chemotherapy can help identify those who respond early to a more intense chemotherapy regimen and switch them to a softer, less toxic regimen, helping to avoid adverse side effects while maintaining the same chance of successful treatment, a Phase 3 trial shows. {read more here}

Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome. In this way, a patient’s therapy can be more effectively tailored to his or her personal response. {read more here}

Data from a combination of FDG-PET and functional MRI (fMRI) scans revealed the extent to which alcohol intake can alter patterns of energy use and neuronal activity in the brain, according to an article published online February 11 in Nature Communications. {read more here}

As measured in PET scans, older adults with apnea had significantly higher levels of tau in the entorhinal cortex on average than those who did not have apnea, after controlling for age, sex, education, cardiovascular risk, and other factors, reported Diego Carvalho, MD, of the Mayo Clinic in Rochester, Minnesota, and colleagues, in an early-release abstract from the American Academy of Neurology meeting to be held here in May. {read more here}